Respiratory Care Devices Market - Global Forecast to 2030
商品番号 : SMB-8136
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年7月 |
| ページ数 | 475 |
| 図表数 | 650 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、呼吸ケア機器市場を分析し、製品タイプ、用途、エンドユーザー、地域といった様々なセグメントに基づいて、市場規模と将来の成長ポテンシャルを推定することを目的としています。また、主要プレーヤーの競合分析に加え、企業概要、サービス内容、最近の動向、主要な市場戦略についても解説しています。
The global respiratory care devices market is projected to reach USD 33.6 billion by 2030 from USD 23.6 billion in 2025, at a CAGR of 7.3% during the forecast period.
世界の呼吸ケア機器市場は、予測期間中に年平均成長率7.3%で成長し、2025年の236億米ドルから2030年には336億米ドルに達すると予測されています。
Various demographic, medical, and environmental determinants form a package fueling market growth in respiratory care equipment. One of them is the increase in the global incidence of respiratory disease. Respiratory diseases such as asthma, sleep apnea, and chronic obstructive pulmonary disease (COPD) are typical examples of respiratory disease, largely because of smoking, aging, and increasingly increasing levels of air pollution. Respiratory support awareness increased with mass deployment of spending on ventilators, oxygen therapy, and monitoring devices during the COVID-19 period.
人口動態、医学、環境といった様々な要因が、呼吸器ケア機器市場の成長を牽引しています。その一つが、世界的な呼吸器疾患の発生率の増加です。喘息、睡眠時無呼吸症、慢性閉塞性肺疾患（COPD）といった呼吸器疾患は、喫煙、高齢化、そして大気汚染の増加といった要因が主な原因で、呼吸器疾患の代表的な例です。COVID-19の流行期には、人工呼吸器、酸素療法、モニタリング機器への支出が急増し、呼吸サポートへの意識が高まりました。
By product type, the therapeutic devices segment is expected to have the largest market share in the respiratory care devices market.
Therapeutic devices are essential in the treatment and management of most acute and chronic respiratory diseases. They are employed to provide life-supporting respiratory therapy to COPD, asthma, sleep apnea, and respiratory failure patients. The devices include high-flow nasal cannula systems, CPAP and BiPAP devices, nebulizers, ventilators, and oxygen concentrators. The therapeutic equipment market has expanded multi-fold due to the need for long-term home respiratory therapy, the global burden of chronic disease, and hospitalization.
By disease indication, the COPD segment is expected to have the largest market share in the respiratory care devices market.
The respiratory care equipment is dominated by Chronic Obstructive Pulmonary Disease (COPD), which is increasingly a global disease, especially in the geriatric population. This is because of the higher demand for non-invasive ventilators, oxygen concentrators, nebulizers, and monitors. Since COPD is a progressive and irreversible disease, constant attention and long-term respiratory treatment are required for the same. The disease is also caused by high-risk factors prevalent in developing and industrialized societies, including smoking, air pollution, and occupational exposures. Since COPD is hospitalized and has exacerbations, repeated use of respiratory equipment in the home and hospital setting is necessitated.
North America is expected to have the largest market share in the respiratory care devices market.
In North America, the increasing prevalence of chronic respiratory conditions such as asthma, sleep apnea, and COPD can be attributed to an aging population, a long history of smoking, and the growing rates of obesity. The region has a robust healthcare system and a growing awareness of the importance of respiratory health, which allows for early detection and treatment of these conditions. The COVID-19 pandemic boosted the demand for ventilators and oxygen therapy equipment. Medical device manufacturers improved reimbursement policies. There has been a rapid adoption of innovative technologies such as respiratory devices that integrate telehealth and remote monitoring have all played a role in shaping this market.
A breakdown of the primary participants (supply-side) for the respiratory care devices market referred to in this report is provided below:
- By Company Type: Tier 1: 35%, Tier 2: 40%, and Tier 3: 25%
- By Designation: C-level: 45%, Director Level: 35%, and Others: 20%
- By Region: North America: 27%, Europe: 25%, Asia Pacific: 30%, Latin America: 8%, Middle East & Africa: 10%
Prominent players in the respiratory care devices market are Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), ResMed Inc. (US), Fisher & Paykel Healthcare Limited (New Zealand), and Drägerwerk AG & Co. KGaA (Germany).
Research Coverage
The report analyzes the respiratory care devices market and aims to estimate the market size and future growth potential of this market based on various segments such as product type, application, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants by providing information on the closest approximations of the revenue numbers for the overall respiratory care devices market. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
Analysis of key drivers (increasing prevalence of respiratory diseases, surge in preterm births, Growing outbreaks of infectious diseases affecting respiratory system, rising issue of sleep disorders, increasing focus on improved patient outcomes, rising R&D investments for medical devices), restraints (unfavorable reimbursement scenario, availability of low-cost products from local manufacturers, high cost of continuous positive airway pressure machines), opportunities (growing demand for home care therapeutic devices, Opportunities in emerging markets, increasing preference for self-testing, growing awareness about ill effects of untreated sleep apnea) and challenges (low awareness and lack of diagnosis of respiratory diseases, harmful effects of respiratory care devices on neonates, lack of patient compliance with CPAP therapy)
- Market Penetration: It includes extensive information on products offered by the major players in the global respiratory care devices market. The report includes various segments in product type, disease indication, end user, and region.
- Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global respiratory care devices market
- Market Development: Thorough knowledge and analysis of the profitable rising markets by type, disease indication, end user, and region.
- Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global respiratory care devices market
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global respiratory care devices market.
Table of Contents
1 INTRODUCTION 37
1.1 STUDY OBJECTIVES 37
1.2 MARKET DEFINITION 37
1.2.1 INCLUSIONS AND EXCLUSIONS 38
1.3 MARKET SCOPE 39
1.3.1 MARKETS COVERED 39
1.3.2 YEARS CONSIDERED 40
1.4 CURRENCY CONSIDERED 40
1.5 STAKEHOLDERS 41
1.6 LIMITATIONS 41
1.7 SUMMARY OF CHANGES 41
2 RESEARCH METHODOLOGY 43
2.1 RESEARCH DATA 43
2.1.1 SECONDARY DATA 44
2.1.1.1 Key data from secondary sources 45
2.1.2 PRIMARY DATA 45
2.1.2.1 Key data from primary sources 47
2.1.2.2 Key industry insights 47
2.2 MARKET SIZE ESTIMATION 49
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 57
2.4 ASSUMPTIONS 58
2.4.1 MARKET SHARE ASSUMPTIONS 58
2.4.2 RESEARCH ASSUMPTIONS 58
2.5 RISK ASSESSMENT 58
2.6 METHODOLOGY-RELATED LIMITATIONS 58
3 EXECUTIVE SUMMARY 59
4 PREMIUM INSIGHTS 63
4.1 RESPIRATORY CARE DEVICES MARKET OVERVIEW 63
4.2 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, 2024 64
4.3 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 65
4.4 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHIC MIX 65
4.5 RESPIRATORY CARE DEVICES MARKET: DEVELOPING VS. DEVELOPED MARKETS 66
5 MARKET OVERVIEW 67
5.1 INTRODUCTION 67
5.2 MARKET DYNAMICS 67
5.2.1 DRIVERS 68
5.2.1.1 Rising prevalence of respiratory diseases 68
5.2.1.1.1 Rapid growth in global geriatric population 68
5.2.1.1.2 Urbanization and growing pollution levels 69
5.2.1.1.3 Growing tobacco consumption 70
5.2.1.1.4 Increased adoption of sedentary lifestyles 71
5.2.1.2 Surging incidence rate of preterm births 71
5.2.1.3 Growing outbreaks of infectious diseases affecting respiratory systems 72
5.2.1.4 Rising population with sleep disorders 72
5.2.1.5 Improved patient outcomes using respiratory care devices 73
5.2.1.6 Rising R&D investments for technological advancement of medical devices 73
5.2.2 RESTRAINTS 74
5.2.2.1 Unfavorable reimbursement scenario for respiratory care diagnostics 74
5.2.2.2 Availability of low-cost products from local manufacturers 74
5.2.2.3 High cost of CPAP machines 75
5.2.3 OPPORTUNITIES 75
5.2.3.1 Growing demand for home care therapeutic devices 75
5.2.3.2 Market growth opportunities in Asia Pacific 76
5.2.3.3 Increasing preference for self-testing 76
5.2.3.4 Growing awareness about ill effects of untreated sleep apnea 77
5.2.4 CHALLENGES 78
5.2.4.1 Low awareness and lack of diagnosis of respiratory diseases 78
5.2.4.2 Harmful effects of certain respiratory care devices on neonates 78
5.2.4.3 Lack of patient compliance with CPAP therapy 79
5.3 REGULATORY LANDSCAPE 79
5.4 REGULATORY FRAMEWORK 79
5.4.1 NORTH AMERICA 79
5.4.1.1 US 79
5.4.1.2 Canada 80
5.4.2 EUROPE 80
5.4.3 ASIA PACIFIC 81
5.4.3.1 Japan 81
5.4.3.2 China 82
5.4.3.3 India 83
5.4.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
5.5 TECHNOLOGY ANALYSIS 85
5.5.1 KEY TECHNOLOGIES 85
5.5.1.1 OXYGEN THERAPY SYSTEMS 85
5.5.1.2 AIRWAY MANAGEMENT DEVICES 85
5.5.1.3 PULMONARY FUNCTION TESTING (PFT) DEVICES 85
5.5.1.4 MONITORING SENSORS 86
5.5.2 COMPLEMENTARY TECHNOLOGIES 86
5.5.2.1 TELEMEDICINE PLATFORMS 86
5.5.2.2 MOBILE HEALTH (MHEALTH) APPS 87
5.5.2.3 WEARABLE RESPIRATORY TRACKERS 87
5.5.3 ADJACENT TECHNOLOGIES 87
5.5.3.1 SMART INHALERS 87
5.5.3.2 ENVIRONMENTAL SENSING DEVICES 87
5.6 INDUSTRY TRENDS 88
5.6.1 MINIATURIZATION AND PORTABILITY 88
5.6.2 SMART CONNECTIVITY AND IOT (INTERNET OF THINGS) INTEGRATION 88
5.6.3 GROWING DEMAND FOR MULTIMODAL VENTILATION 89
5.6.4 RISING ADOPTION OF NON-INVASIVE VENTILATION 89
5.6.5 PERSONALIZED TREATMENT SOLUTIONS 90
5.7 VALUE CHAIN ANALYSIS 90
5.8 SUPPLY CHAIN ANALYSIS 91
5.9 TRADE ANALYSIS 92
5.9.1 TRADE ANALYSIS FOR RESPIRATORY CARE DEVICES PRODUCTS 92
5.10 PRICING ANALYSIS 93
5.10.1 AVERAGE SELLING PRICE OF RESPIRATORY CARE DEVICES, BY KEY PLAYER, 2024 (USD) 93
5.10.2 AVERAGE SELLING PRICE OF RESPIRATORY CARE DEVICES, BY REGION, 2024 (USD) 94
5.11 REIMBURSEMENT SCENARIO 94
5.12 PORTER’S FIVE FORCES ANALYSIS 95
5.12.1 THREAT OF NEW ENTRANTS 96
5.12.2 THREAT OF SUBSTITUTES 96
5.12.3 BARGAINING POWER OF SUPPLIERS 96
5.12.4 BARGAINING POWER OF BUYERS 97
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 97
5.13 ADJACENT MARKET ANALYSIS 97
5.14 PATENT ANALYSIS 98
5.15 ECOSYSTEM COVERAGE 99
5.16 KEY CONFERENCES AND EVENTS (2025-2026) 100
5.17 KEY CONFERENCES & EVENTS DURING 2025-2026 100
5.18 CASE STUDIES 101
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 103
5.20 KEY STAKEHOLDERS & BUYING CRITERIA 104
5.20.1 KEY STAKEHOLDERS IN BUYING PROCESS 104
5.21 KEY BUYING CRITERIA 105
5.22 INVESTMENT/VENTURE CAPITAL 106
5.23 UNMET NEEDS/END-USER EXPECTATIONS IN RESPIRATORY CARE DEVICES MARKET 106
5.24 IMPACT OF ARTIFICIAL INTELLIGENCE (AI) ON RESPIRATORY CARE DEVICES MARKET 107
5.25 IMPACT OF 2025 US TARIFF – OVERVIEW 108
5.25.1 INTRODUCTION 108
5.26 KEY TARIFF RATES 109
5.27 PRICE IMPACT ANALYSIS 110
5.27.1 IMPACT ON COUNTRY/REGION 110
5.27.1.1 US 110
5.27.1.2 Europe 111
5.27.1.3 Asia Pacific 111
5.28 IMPACT ON END-USER INDUSTRIES 111
6 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT 113
6.1 INTRODUCTION 114
6.2 THERAPEUTIC RESPIRATORY CARE DEVICES 115
6.2.1 PAP DEVICES 118
6.2.1.1 CPAP devices 120
6.2.1.1.1 Growing popularity of nasal CPAP therapies to drive demand 120
6.2.1.2 APAP devices 122
6.2.1.2.1 Rising awareness among sleep specialists and patients regarding additional features of APAP devices to boost market 122
6.2.1.3 BiPAP devices 124
6.2.1.3.1 Increasing number of hospitals to strengthen market 124
6.2.2 VENTILATORS 125
6.2.2.1 ICU ventilators 127
6.2.2.1.1 High-end ventilators 130
6.2.2.1.1.1 Improving healthcare infrastructure and rising healthcare expenditure to drive market 130
6.2.2.1.2 Mid-end ventilators 131
6.2.2.1.2.1 Better affordability and accessibility of mid-end ventilators than high-end models to support market growth 131
6.2.2.1.3 Basic ventilators 133
6.2.2.1.3.1 Expanding access to critical healthcare facilities in developing countries to spur demand 133
6.2.2.2 Portable/Transportable ventilators 134
6.2.2.2.1 Increasing demand for home care to boost segmental growth 134
6.2.3 NEBULIZERS 137
6.2.3.1 Jet nebulizers 140
6.2.3.1.1 Increasing prevalence of respiratory conditions to augment market 140
6.2.3.2 Mesh nebulizers 142
6.2.3.2.1 Deployment of advanced aerosolization technology to drive market 142
6.2.3.3 Ultrasonic nebulizers 143
6.2.3.3.1 Adjustable settings for particle size and treatment duration to boost market 143
6.2.4 HUMIDIFIERS 144
6.2.4.1 Heated humidifiers 145
6.2.4.1.1 Ease of control and customizability to fuel market 145
6.2.4.2 Passover humidifiers 148
6.2.4.2.1 Minimal maintenance and simple technology to spur demand 148
6.2.5 OXYGEN CONCENTRATORS 149
6.2.5.1 Fixed oxygen concentrators 151
6.2.5.1.1 Better access to healthcare services to spur demand 151
6.2.5.2 Portable oxygen concentrators 152
6.2.5.2.1 Low weight and easy setup to drive segmental growth 152
6.2.6 INHALERS 154
6.2.6.1 Metered-dose inhalers (MDIs) 155
6.2.6.1.1 Ongoing advancements in MDI technology to support market growth 155
6.2.6.2 Dry powder inhalers (DPIs) 157
6.2.6.2.1 Developments in particle engineering and powder formulations to boost segmental growth 157
6.2.7 REUSABLE RESUSCITATORS 158
6.2.7.1 Disposable and reusable nature to drive demand 158
6.2.8 NITRIC OXIDE DELIVERY UNITS 159
6.2.8.1 Rising emphasis of companies on developing innovative and advanced nitric oxide delivery units to drive market 159
6.2.9 OXYGEN HOODS 161
6.2.9.1 Growing prevalence of respiratory diseases in kids to drive market growth 161
6.3 MONITORING DEVICES 162
6.3.1 PULSE OXIMETERS 164
6.3.1.1 Pulse oximeter sensors 165
6.3.1.1.1 Development of advanced sensors with embedded chips to boost segmental growth 165
6.3.1.2 Pulse oximeter equipment 166
6.3.1.2.1 Growing prevalence of chronic respiratory conditions to boost demand 166
6.3.2 CAPNOGRAPHS 168
6.3.2.1 Ongoing R&D on capnographs to offer lucrative growth opportunities 168
6.3.3 GAS ANALYZERS 170
6.3.3.1 Increasing demand for point-of-care testing to drive demand 170
6.4 DIAGNOSTIC RESPIRATORY CARE DEVICES 171
6.4.1 SPIROMETERS 173
6.4.1.1 Rising technological advancements in spirometers to
support market growth 173
6.4.2 POLYSOMNOGRAPHY DEVICES (PSG DEVICES) 175
6.4.2.1 Rising incidence of obstructive sleep apnea to drive demand 175
6.4.3 PEAK FLOW METERS 177
6.4.3.1 Low-cost and uncomplicated nature to drive segmental growth 177
6.4.4 OTHER DIAGNOSTIC DEVICES 178
6.5 CONSUMABLES & ACCESSORIES 180
6.5.1 MASKS 181
6.5.1.1 Reusable masks 183
6.5.1.1.1 Growing concerns related to air pollution to fuel demand 183
6.5.1.2 Disposable masks 184
6.5.1.2.1 Stringent government mandates on wearing masks to spur demand 184
6.5.2 DISPOSABLE RESUSCITATORS 185
6.5.2.1 Growing focus on reducing cross-contamination cases in patients to foster segmental growth 185
6.5.3 TRACHEOSTOMY TUBES 186
6.5.3.1 Introduction of advanced products with ergonomic designs to drive market growth 186
6.5.4 BREATHING CIRCUITS 188
6.5.4.1 Healthcare professionals’ efforts to improve infection control practices to drive demand 188
6.5.5 NASAL CANNULAE 189
6.5.5.1 Increasing focus on minimally invasive surgery techniques to fuel demand 189
6.5.6 OTHER CONSUMABLES & ACCESSORIES 191
7 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION 192
7.1 INTRODUCTION 193
7.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) 195
7.2.1 RISING INDOOR AND OUTDOOR AIR POLLUTION LEVELS TO DRIVE MARKET 195
7.3 SLEEP APNEA 196
7.3.1 GROWING INCIDENCE OF OBESITY AND CARDIOVASCULAR DISEASES TO FAVOR MARKET GROWTH 196
7.4 ASTHMA 199
7.4.1 INCREASING AIR POLLUTION AND GROWING USE OF TOBACCO-BASED PRODUCTS TO DRIVE MARKET 199
7.5 INFECTIOUS DISEASES 201
7.5.1 GROWING NUMBER OF TB PATIENTS TO BOOST MARKET GROWTH 201
7.6 OTHER DISEASE INDICATIONS 203
8 RESPIRATORY CARE DEVICES MARKET, BY END USER 204
8.1 INTRODUCTION 205
8.2 HOSPITALS 206
8.2.1 GROWING NUMBER OF HOSPITALS IN EMERGING ECONOMIES
TO DRIVE MARKET 206
8.3 HOME CARE SETTINGS 208
8.3.1 INCREASING ACCEPTANCE OF HOME CARE DEVICES BY PATIENTS
TO BOOST GROWTH 208
8.4 AMBULATORY CARE CENTERS (ACCS) 210
8.4.1 IMPROVED PATIENT EXPERIENCE IN AMBULATORY CARE CENTERS
TO DRIVE MARKET 210
8.5 OTHER END USERS 211
9 RESPIRATORY CARE DEVICES MARKET, BY REGION 213
9.1 INTRODUCTION 214
9.2 NORTH AMERICA 215
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 222
9.2.2 US 223
9.2.2.1 Rapid growth in geriatric population to boost market 223
9.2.3 CANADA 230
9.2.3.1 Large pool of undiagnosed patients and vaping trends drive market 230
9.3 EUROPE 237
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 243
9.3.2 GERMANY 244
9.3.2.1 Increasing public healthcare expenditure to foster market growth 244
9.3.3 FRANCE 251
9.3.3.1 High prevalence of COPD to surge demand 251
9.3.4 UK 257
9.3.4.1 Growing demand for minimally invasive surgeries to drive market 257
9.3.5 ITALY 263
9.3.5.1 Growing involvement of private sector in healthcare market to drive market 263
9.3.6 SPAIN 270
9.3.6.1 Need to improve healthcare infrastructure due to aging demographic to drive demand 270
9.3.7 REST OF EUROPE 276
9.4 ASIA PACIFIC 282
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 290
9.4.2 JAPAN 291
9.4.2.1 Availability of universal healthcare reimbursement policy to drive market 291
9.4.3 CHINA 297
9.4.3.1 Initiatives to modernize healthcare system and reimbursement facilities to support market growth 297
9.4.4 INDIA 303
9.4.4.1 Increasing focus of global players on domestic market to drive market 303
9.4.5 AUSTRALIA 310
9.4.5.1 High prevalence of chronic lung diseases to drive demand 310
9.4.6 SOUTH KOREA 316
9.4.6.1 Expanding geriatric population to fuel market 316
9.4.7 REST OF ASIA PACIFIC 322
9.5 LATIN AMERICA 328
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 334
9.5.2 BRAZIL 334
9.5.2.1 Government initiatives to improve healthcare sector to drive market 334
9.5.3 MEXICO 341
9.5.3.1 Rising obesity rate to increase incidence of respiratory diseases 341
9.5.4 REST OF LATIN AMERICA 347
9.6 MIDDLE EAST & AFRICA 353
9.6.1 MACROECONOMIC OUTLOOK FOR MEA 360
9.6.2 GCC COUNTRIES 361
9.6.2.1 INCREASING INCIDENCE OF RESPIRATORY DISEASES IN GCC DRIVES MARKET 361
9.6.3 REST OF MIDDLE EAST & AFRICA 367
10 COMPETITIVE LANDSCAPE 374
10.1 OVERVIEW 374
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 374
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN RESPIRATORY CARE DEVICES MARKET 375
10.3 REVENUE ANALYSIS 377
10.4 MARKET SHARE ANALYSIS 378
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 380
10.5.1 STARS 381
10.5.2 EMERGING LEADERS 381
10.5.3 PERVASIVE PLAYERS 381
10.5.4 PARTICIPANTS 381
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 383
10.5.5.1 Company footprint 383
10.5.5.2 Region footprint 384
10.5.5.3 Product type footprint 385
10.5.5.4 Disease indication footprint 386
10.5.5.5 End user footprint 387
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 388
10.6.1 PROGRESSIVE COMPANIES 388
10.6.2 DYNAMIC COMPANIES 388
10.6.3 STARTING BLOCKS 388
10.6.4 RESPONSIVE COMPANIES 389
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 390
10.7 VALUATION & FINANCIAL METRICS 391
10.7.1 FINANCIAL METRICS 391
10.7.2 COMPANY VALUATION 391
10.8 BRAND/PRODUCT COMPARISON 392
10.9 COMPETITIVE SCENARIO 393
10.9.1 PRODUCT & SERVICE LAUNCHES AND APPROVALS 393
10.9.2 DEALS 394
10.9.3 EXPANSIONS 395
10.9.4 OTHER DEVELOPMENTS 395
11 COMPANY PROFILES 396
11.1 KEY PLAYERS 396
11.1.1 KONINKLIJKE PHILIPS N.V. 396
11.1.1.1 Business overview 396
11.1.1.2 Products offered 397
11.1.1.3 Recent developments 399
11.1.1.3.1 Product launches & approvals 399
11.1.1.4 MnM view 399
11.1.1.4.1 Right to win 399
11.1.1.4.2 Strategic choices 399
11.1.1.4.3 Weaknesses & competitive threats 400
11.1.2 MEDTRONIC 401
11.1.2.1 Business overview 401
11.1.2.2 Products offered 402
11.1.2.3 Recent developments 403
11.1.2.3.1 Product launches & approvals 403
11.1.2.3.2 Other developments 404
11.1.2.4 MnM view 404
11.1.2.4.1 Right to win 404
11.1.2.4.2 Strategic choices 404
11.1.2.4.3 Weaknesses & competitive threats 404
11.1.3 RESMED INC. 405
11.1.3.1 Business overview 405
11.1.3.2 Products offered 406
11.1.3.3 Recent developments 408
11.1.3.3.1 Product launches & approvals 408
11.1.3.3.2 Deals 409
11.1.3.4 MnM view 410
11.1.3.4.1 Right to win 410
11.1.3.4.2 Strategic choices 410
11.1.3.4.3 Weaknesses & competitive threats 410
11.1.4 FISHER & PAYKEL HEALTHCARE LIMITED 411
11.1.4.1 Business overview 411
11.1.4.2 Products offered 412
11.1.4.3 Recent developments 414
11.1.4.3.1 Product launches & approvals 414
11.1.4.4 MnM view 415
11.1.4.4.1 Right to win 415
11.1.4.4.2 Strategic choices 415
11.1.4.4.3 Weaknesses & competitive threats 416
11.1.5 DRÄGERWERK AG & CO. KGAA 417
11.1.5.1 Business overview 417
11.1.5.2 Products offered 418
11.1.5.3 Recent developments 419
11.1.5.3.1 Product launches & approvals 419
11.1.5.3.2 Deals 420
11.1.5.3.3 Other developments 420
11.1.5.4 MnM view 420
11.1.5.4.1 Right to win 420
11.1.5.4.2 Strategic choices 421
11.1.5.4.3 Weaknesses & competitive threats 421
11.1.6 MASIMO 422
11.1.6.1 Business overview 422
11.1.6.2 Products offered 423
11.1.6.3 Recent developments 425
11.1.6.3.1 Product launches & approvals 425
11.1.6.3.2 Deals 426
11.1.6.3.3 Other developments 426
11.1.7 GETINGE 427
11.1.7.1 Business overview 427
11.1.7.2 Products offered 428
11.1.7.3 Recent developments 429
11.1.7.3.1 Product launches & approvals 429
11.1.7.3.2 Deals 429
11.1.7.3.3 Expansions 430
11.1.8 NIHON KOHDEN CORPORATION 431
11.1.8.1 Business overview 431
11.1.8.2 Products offered 432
11.1.8.3 Recent developments 433
11.1.8.3.1 Product launches & approvals 433
11.1.8.3.2 Deals 434
11.1.9 GE HEALTHCARE 435
11.1.9.1 Business overview 435
11.1.9.2 Products offered 436
11.1.9.3 Recent developments 437
11.1.9.3.1 Deals 437
11.1.9.3.2 Other developments 437
11.1.10 HILLROM & WELCH ALLYN (BAXTER INTERNATIONAL, INC) 438
11.1.10.1 Business overview 438
11.1.10.2 Products offered 439
11.1.10.3 Recent developments 440
11.1.10.3.1 Product launches & approvals 440
11.1.10.3.2 Deals 441
11.1.11 ADAPTHEALTH, LLC 442
11.1.11.1 Business overview 442
11.1.11.2 Products offered 443
11.1.12 TELEFLEX INCORPORATED 444
11.1.12.1 Business overview 444
11.1.12.2 Products offered 445
11.1.13 AIR LIQUIDE 446
11.1.13.1 Business overview 446
11.1.13.2 Products offered 447
11.1.13.3 Recent developments 449
11.1.13.3.1 Deals 449
11.1.14 ICU MEDICAL, INC. 450
11.1.14.1 Business overview 450
11.1.14.2 Products offered 451
11.1.14.3 Recent developments 452
11.1.14.3.1 Product launches & approvals 452
11.1.14.3.2 Deals 452
11.1.15 HAMILTON MEDICAL 453
11.1.15.1 Business overview 453
11.1.15.2 Products offered 453
11.1.15.3 Recent developments 454
11.1.15.3.1 Product launches & approvals 454
11.2 OTHER PLAYERS 455
11.2.1 MEDLINE INDUSTRIES, LP 455
11.2.2 ALLIED MEDICAL LLC 457
11.2.3 NONIN 458
11.2.4 APEX MEDICAL 459
11.2.5 ROTECH HEALTHCARE, INC. 460
11.2.6 LÖWENSTEIN MEDICAL SE & CO. KG 461
11.2.7 WEINMANN EMERGENCY MEDICAL TECHNOLOGY GMBH + CO. KG 462
11.2.8 DRIVE DEVILBISS HEALTHCARE 463
11.2.9 OMRON HEALTHCARE, INC. 464
11.2.10 HUM GMBH 465
12 APPENDIX 466
12.1 DISCUSSION GUIDE 466
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 471
12.3 CUSTOMIZATION OPTIONS 473
12.4 RELATED REPORTS 473
12.5 AUTHOR DETAILS 474
LIST OF TABLES
TABLE 1 ANNUAL AVERAGE EXCHANGE RATE FOR CURRENCY CONVERSION, 2020–2024 40
TABLE 2 RESEARCH ASSUMPTIONS 58
TABLE 3 RISK ASSESSMENT: RESPIRATORY CARE DEVICES MARKET 58
TABLE 4 REGION-WISE DATA ON LIFESTYLE DISEASES 70
TABLE 5 TOP 10 COUNTRIES WITH HIGHEST RATES OF PRETERM BIRTH PER
100 LIVE BIRTHS 71
TABLE 6 PRODUCT LAUNCHES 74
TABLE 7 INITIATIVES TO PROMOTE AWARENESS ABOUT UNTREATED SLEEP APNEA 77
TABLE 8 US: CLASSIFICATION OF MEDICAL EQUIPMENT 79
TABLE 9 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 80
TABLE 10 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY
OF REGISTRATION PROCESS 80
TABLE 11 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY
OF REGISTRATION PROCESS 81
TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 82
TABLE 13 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 82
TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 83
TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 83
TABLE 16 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT
AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 17 IMPORT DATA FOR RESPIRATORY CARE DEVICES (HS CODE 901920),
BY COUNTRY, 2020–2024 (USD THOUSAND) 92
TABLE 18 EXPORT DATA FOR RESPIRATORY CARE DEVICES (HS CODE 901920),
BY COUNTRY, 2020–2024 (USD THOUSAND) 93
TABLE 19 RESPIRATORY CARE DEVICES MARKET: REIMBURSEMENT SCENARIO 94
TABLE 20 RESPIRATORY CARE DEVICES MARKET: PORTERS FIVE FORCE ANALYSIS 96
TABLE 21 RESPIRATORY CARE DEVICES MARKET: DETAILED LIST OF
CONFERENCES & EVENTS 100
TABLE 22 CASE STUDY 1: LONG-TERM VENTILATION WITH VARIABLE PSV 101
TABLE 23 CASE STUDY 2: OPTIMAL UTILIZATION OF MECHANICAL VENTILATOR
AT TERTIARY CARE HOSPITAL DURING COVID-19 PANDEMIC 102
TABLE 24 CASE STUDY 3: CHANGING PATTERNS IN LONG-TERM NON-INVASIVE VENTILATION 103
TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RESPIRATORY
CARE DEVICES 105
TABLE 26 KEY BUYING CRITERIA FOR RESPIRATORY CARE DEVICES 105
TABLE 27 RESPIRATORY CARE DEVICES MARKET: UNMET NEEDS 106
TABLE 28 RESPIRATORY CARE DEVICES MARKET: APPLICATION OF ARTIFICIAL INTELLIGENCE 107
TABLE 29 US-ADJUSTED RECIPROCAL TARIFF RATES 109
TABLE 30 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR RESPIRATORY CARE DEVICES 110
TABLE 31 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 114
TABLE 32 RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115
TABLE 33 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 116
TABLE 34 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 117
TABLE 35 PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 118
TABLE 36 PAP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119
TABLE 37 PAP DEVICES MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 119
TABLE 38 MAJOR PLAYERS OFFERING CPAP DEVICES 120
TABLE 39 CPAP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121
TABLE 40 MAJOR PLAYERS OFFERING APAP DEVICES 122
TABLE 41 APAP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 123
TABLE 42 MAJOR PLAYERS OFFERING BIPAP DEVICES 124
TABLE 43 BIPAP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125
TABLE 44 VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 126
TABLE 45 VENTILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126
TABLE 46 VENTILATORS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 127
TABLE 47 MAJOR PLAYERS OFFERING ICU VENTILATORS 128
TABLE 48 ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 129
TABLE 49 ICU VENTILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129
TABLE 50 HIGH-END VENTILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 131
TABLE 51 MID-END VENTILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 132
TABLE 52 BASIC VENTILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 53 MAJOR PLAYERS OFFERING PORTABLE/TRANSPORTABLE VENTILATORS 134
TABLE 54 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 136
TABLE 55 MAJOR PLAYERS OFFERING NEBULIZERS 137
TABLE 56 NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 138
TABLE 57 NEBULIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 58 NEBULIZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 140
TABLE 59 JET NEBULIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 60 MESH NEBULIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 61 ULTRASONIC NEBULIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143
TABLE 62 HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 144
TABLE 63 HUMIDIFIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 64 MAJOR PLAYERS OFFERING HEATED HUMIDIFIERS 146
TABLE 65 HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 147
TABLE 66 MAJOR PLAYERS OFFERING PASSOVER HUMIDIFIERS 148
TABLE 67 PASSOVER HUMIDIFIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 149
TABLE 68 MAJOR PLAYERS OFFERING OXYGEN CONCENTRATORS 150
TABLE 69 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 150
TABLE 70 OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 151
TABLE 71 FIXED OXYGEN CONCENTRATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 152
TABLE 72 PORTABLE OXYGEN CONCENTRATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 153
TABLE 73 INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 154
TABLE 74 INHALERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 155
TABLE 75 METERED-DOSE INHALERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 156
TABLE 76 DRY POWDER INHALERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 157
TABLE 77 MAJOR PLAYERS OFFERING REUSABLE RESUSCITATORS 158
TABLE 78 REUSABLE RESUSCITATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 159
TABLE 79 MAJOR PLAYERS OFFERING NITRIC OXIDE DELIVERY UNITS 160
TABLE 80 NITRIC OXIDE DELIVERY UNITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 160
TABLE 81 MAJOR PLAYERS OFFERING OXYGEN HOODS 161
TABLE 82 OXYGEN HOODS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 162
TABLE 83 RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 163
TABLE 84 RESPIRATORY CARE MONITORING DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 163
TABLE 85 MAJOR PLAYERS OFFERING PULSE OXIMETERS 164
TABLE 86 PULSE OXIMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 164
TABLE 87 PULSE OXIMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 88 PULSE OXIMETER SENSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 166
TABLE 89 MAJOR PLAYERS OFFERING PULSE OXIMETER EQUIPMENT 167
TABLE 90 PULSE OXIMETER EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168
TABLE 91 MAJOR PLAYERS OFFERING CAPNOGRAPHS 169
TABLE 92 CAPNOGRAPHS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 169
TABLE 93 MAJOR PLAYERS OFFERING GAS ANALYZERS 170
TABLE 94 GAS ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171
TABLE 95 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 172
TABLE 96 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 172
TABLE 97 MAJOR PLAYERS OFFERING SPIROMETERS 173
TABLE 98 SPIROMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 174
TABLE 99 SPIROMETERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 175
TABLE 100 MAJOR PLAYERS OFFERING POLYSOMNOGRAPHY DEVICES 175
TABLE 101 POLYSOMNOGRAPHY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 176
TABLE 102 MAJOR PLAYERS OFFERING PEAK FLOW METERS 177
TABLE 103 PEAK FLOW METERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 178
TABLE 104 OTHER DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 179
TABLE 105 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2023–2030 (USD MILLION) 180
TABLE 106 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 181
TABLE 107 MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 182
TABLE 108 MASKS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 182
TABLE 109 REUSABLE MASKS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 183
TABLE 110 DISPOSABLE MASKS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 185
TABLE 111 DISPOSABLE RESUSCITATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 186
TABLE 112 TRACHEOSTOMY TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 187
TABLE 113 BREATHING CIRCUITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 189
TABLE 114 NASAL CANNULAE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 190
TABLE 115 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 191
TABLE 116 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION,
2023–2030 (USD MILLION) 193
TABLE 117 DISEASE INDICATION: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 194
TABLE 118 RESPIRATORY CARE DEVICES MARKET FOR COPD, BY COUNTRY,
2023–2030 (USD MILLION) 196
TABLE 119 COUNTRY-WISE DATA ON SLEEP APNEA PATIENTS 197
TABLE 120 RESPIRATORY CARE DEVICES MARKET FOR SLEEP APNEA, BY COUNTRY,
2023–2030 (USD MILLION) 198
TABLE 121 RESPIRATORY CARE DEVICES MARKET FOR ASTHMA, BY COUNTRY,
2023–2030 (USD MILLION) 200
TABLE 122 INCIDENCE OF TB (RATE PER 100,000 POPULATION) 201
TABLE 123 RESPIRATORY CARE DEVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 202
TABLE 124 RESPIRATORY CARE DEVICES MARKET FOR OTHER DISEASE INDICATIONS,
BY COUNTRY, 2023–2030 (USD MILLION) 203
TABLE 125 RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 205
TABLE 126 END USER: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 205
TABLE 127 RESPIRATORY CARE DEVICES MARKET FOR HOSPITALS, BY COUNTRY,
2023–2030 (USD MILLION) 207
TABLE 128 RESPIRATORY CARE DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 209
TABLE 129 RESPIRATORY CARE DEVICES MARKET FOR AMBULATORY CARE CENTERS,
BY COUNTRY, 2023–2030 (USD MILLION) 211
TABLE 130 RESPIRATORY CARE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 212
TABLE 131 RESPIRATORY CARE DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 215
TABLE 132 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 216
TABLE 133 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 217
TABLE 134 NORTH AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 217
TABLE 135 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 218
TABLE 136 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 218
TABLE 137 NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 218
TABLE 138 NORTH AMERICA: ICU VENTILATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 219
TABLE 139 NORTH AMERICA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 219
TABLE 140 NORTH AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 219
TABLE 141 NORTH AMERICA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 220
TABLE 142 NORTH AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 220
TABLE 143 NORTH AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 220
TABLE 144 NORTH AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 221
TABLE 145 NORTH AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 221
TABLE 146 NORTH AMERICA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 221
TABLE 147 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 222
TABLE 148 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 222
TABLE 149 US: KEY MACROINDICATORS 224
TABLE 150 US: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 224
TABLE 151 US: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 225
TABLE 152 US: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 225
TABLE 153 US: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 225
TABLE 154 US: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226
TABLE 155 US: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226
TABLE 156 US: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226
TABLE 157 US: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 227
TABLE 158 US: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 227
TABLE 159 US: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 227
TABLE 160 US: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 228
TABLE 161 US: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 228
TABLE 162 US: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 228
TABLE 163 US: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 229
TABLE 164 US: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION,
2023–2030 (USD MILLION) 229
TABLE 165 US: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 229
TABLE 166 CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020) 230
TABLE 167 CANADA: KEY MACROINDICATORS 231
TABLE 168 CANADA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 231
TABLE 169 CANADA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 232
TABLE 170 CANADA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 171 CANADA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 232
TABLE 172 CANADA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 173 CANADA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 174 CANADA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 175 CANADA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 234
TABLE 176 CANADA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 234
TABLE 177 CANADA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 234
TABLE 178 CANADA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 235
TABLE 179 CANADA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 235
TABLE 180 CANADA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 235
TABLE 181 CANADA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 236
TABLE 182 CANADA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION,
2023–2030 (USD MILLION) 236
TABLE 183 CANADA: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 236
TABLE 184 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 237
TABLE 185 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 238
TABLE 186 EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 238
TABLE 187 EUROPE: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 239
TABLE 188 EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 239
TABLE 189 EUROPE: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 239
TABLE 190 EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 191 EUROPE: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 192 EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 193 EUROPE: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 241
TABLE 194 EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 241
TABLE 195 EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 241
TABLE 196 EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 242
TABLE 197 EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 242
TABLE 198 EUROPE: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 242
TABLE 199 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION,
2023–2030 (USD MILLION) 243
TABLE 200 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 243
TABLE 201 GERMANY: KEY MACROINDICATORS 245
TABLE 202 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 245
TABLE 203 GERMANY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 246
TABLE 204 GERMANY: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 246
TABLE 205 GERMANY: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 246
TABLE 206 GERMANY: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 247
TABLE 207 GERMANY: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 247
TABLE 208 GERMANY: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 247
TABLE 209 GERMANY: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 248
TABLE 210 GERMANY: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 248
TABLE 211 GERMANY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 248
TABLE 212 GERMANY: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 249
TABLE 213 GERMANY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 249
TABLE 214 GERMANY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 249
TABLE 215 GERMANY: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 250
TABLE 216 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 250
TABLE 217 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 250
TABLE 218 FRANCE: KEY MACROINDICATORS 251
TABLE 219 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 251
TABLE 220 FRANCE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 252
TABLE 221 FRANCE: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 252
TABLE 222 FRANCE: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 252
TABLE 223 FRANCE: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 224 FRANCE: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 225 FRANCE: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 226 FRANCE: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254
TABLE 227 FRANCE: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254
TABLE 228 FRANCE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 254
TABLE 229 FRANCE: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 255
TABLE 230 FRANCE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 255
TABLE 231 FRANCE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 255
TABLE 232 FRANCE: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 256
TABLE 233 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION,
2023–2030 (USD MILLION) 256
TABLE 234 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 256
TABLE 235 UK: KEY MACROINDICATORS 257
TABLE 236 UK: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 258
TABLE 237 UK: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 258
TABLE 238 UK: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 259
TABLE 239 UK: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259
TABLE 240 UK: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259
TABLE 241 UK: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 260
TABLE 242 UK: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 260
TABLE 243 UK: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 260
TABLE 244 UK: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 261
TABLE 245 UK: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 261
TABLE 246 UK: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 261
TABLE 247 UK: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 262
TABLE 248 UK: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 262
TABLE 249 UK: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 262
TABLE 250 UK: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION,
2023–2030 (USD MILLION) 263
TABLE 251 UK: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 263
TABLE 252 ITALY: KEY MACROINDICATORS 264
TABLE 253 ITALY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 264
TABLE 254 ITALY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 265
TABLE 255 ITALY: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 265
TABLE 256 ITALY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 265
TABLE 257 ITALY: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 266
TABLE 258 ITALY: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 266
TABLE 259 ITALY: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 266
TABLE 260 ITALY: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 267
TABLE 261 ITALY: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 267
TABLE 262 ITALY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 267
TABLE 263 ITALY: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 268
TABLE 264 ITALY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 268
TABLE 265 ITALY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 268
TABLE 266 ITALY: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 269
TABLE 267 ITALY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION,
2023–2030 (USD MILLION) 269
TABLE 268 ITALY: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 269
TABLE 269 SPAIN: KEY MACROINDICATORS 270
TABLE 270 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 271
TABLE 271 SPAIN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 271
TABLE 272 SPAIN: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 272
TABLE 273 SPAIN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 272
TABLE 274 SPAIN: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 272
TABLE 275 SPAIN: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 273
TABLE 276 SPAIN: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 273
TABLE 277 SPAIN: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 273
TABLE 278 SPAIN: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 274
TABLE 279 SPAIN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 274
TABLE 280 SPAIN: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 274
TABLE 281 SPAIN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 275
TABLE 282 SPAIN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 275
TABLE 283 SPAIN: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 275
TABLE 284 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION,
2023–2030 (USD MILLION) 276
TABLE 285 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 276
TABLE 286 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 277
TABLE 287 REST OF EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 277
TABLE 288 REST OF EUROPE: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 278
TABLE 289 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 278
TABLE 290 REST OF EUROPE: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 278
TABLE 291 REST OF EUROPE: ICU VENTILATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 279
TABLE 292 REST OF EUROPE: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279
TABLE 293 REST OF EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279
TABLE 294 REST OF EUROPE: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 280
TABLE 295 REST OF EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 280
TABLE 296 REST OF EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 280
TABLE 297 REST OF EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 281
TABLE 298 REST OF EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 281
TABLE 299 REST OF EUROPE: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 281
TABLE 300 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 282
TABLE 301 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 282
TABLE 302 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 284
TABLE 303 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 284
TABLE 304 ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 285
TABLE 305 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 285
TABLE 306 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 285
TABLE 307 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 286
TABLE 308 ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 286
TABLE 309 ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 286
TABLE 310 ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 287
TABLE 311 ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 287
TABLE 312 ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 287
TABLE 313 ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 288
TABLE 314 ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 288
TABLE 315 ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 288
TABLE 316 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 289
TABLE 317 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 289
TABLE 318 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 289
TABLE 319 JAPAN: KEY MACROINDICATORS 291
TABLE 320 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 291
TABLE 321 JAPAN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 292
TABLE 322 JAPAN: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 292
TABLE 323 JAPAN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 292
TABLE 324 JAPAN: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 293
TABLE 325 JAPAN: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 293
TABLE 326 JAPAN: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 293
TABLE 327 JAPAN: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 294
TABLE 328 JAPAN: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 294
TABLE 329 JAPAN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 294
TABLE 330 JAPAN: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 295
TABLE 331 JAPAN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 295
TABLE 332 JAPAN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 295
TABLE 333 JAPAN: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 296
TABLE 334 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION,
2023–2030 (USD MILLION) 296
TABLE 335 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 296
TABLE 336 CHINA: KEY MACROINDICATORS 297
TABLE 337 CHINA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 298
TABLE 338 CHINA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 298
TABLE 339 CHINA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 299
TABLE 340 CHINA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 299
TABLE 341 CHINA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 299
TABLE 342 CHINA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 300
TABLE 343 CHINA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 300
TABLE 344 CHINA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 300
TABLE 345 CHINA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 301
TABLE 346 CHINA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 301
TABLE 347 CHINA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 301
TABLE 348 CHINA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 302
TABLE 349 CHINA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 302
TABLE 350 CHINA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 302
TABLE 351 CHINA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION,
2023–2030 (USD MILLION) 303
TABLE 352 CHINA: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 303
TABLE 353 INDIA: KEY MACROINDICATORS 304
TABLE 354 INDIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 304
TABLE 355 INDIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 305
TABLE 356 INDIA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 305
TABLE 357 INDIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 305
TABLE 358 INDIA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 306
TABLE 359 INDIA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 306
TABLE 360 INDIA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 306
TABLE 361 INDIA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 307
TABLE 362 INDIA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 307
TABLE 363 INDIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 307
TABLE 364 INDIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 308
TABLE 365 INDIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 308
TABLE 366 INDIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 308
TABLE 367 INDIA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 309
TABLE 368 INDIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION,
2023–2030 (USD MILLION) 309
TABLE 369 INDIA: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 309
TABLE 370 AUSTRALIA: KEY MACROINDICATORS 310
TABLE 371 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 310
TABLE 372 AUSTRALIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 311
TABLE 373 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 311
TABLE 374 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 311
TABLE 375 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 312
TABLE 376 AUSTRALIA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 312
TABLE 377 AUSTRALIA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 312
TABLE 378 AUSTRALIA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 313
TABLE 379 AUSTRALIA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 313
TABLE 380 AUSTRALIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 313
TABLE 381 AUSTRALIA: PULSE OXIMETERS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 314
TABLE 382 AUSTRALIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 314
TABLE 383 AUSTRALIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 314
TABLE 384 AUSTRALIA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 315
TABLE 385 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 315
TABLE 386 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 315
TABLE 387 SOUTH KOREA: KEY MACROINDICATORS 316
TABLE 388 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 316
TABLE 389 SOUTH KOREA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 317
TABLE 390 SOUTH KOREA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 317
TABLE 391 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 317
TABLE 392 SOUTH KOREA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 318
TABLE 393 SOUTH KOREA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 318
TABLE 394 SOUTH KOREA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 318
TABLE 395 SOUTH KOREA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 319
TABLE 396 SOUTH KOREA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 319
TABLE 397 SOUTH KOREA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 319
TABLE 398 SOUTH KOREA: PULSE OXIMETERS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 320
TABLE 399 SOUTH KOREA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 320
TABLE 400 SOUTH KOREA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 320
TABLE 401 SOUTH KOREA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 321
TABLE 402 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 321
TABLE 403 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 321
TABLE 404 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 322
TABLE 405 REST OF ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 323
TABLE 406 REST OF ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 323
TABLE 407 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 323
TABLE 408 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 324
TABLE 409 REST OF ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 324
TABLE 410 REST OF ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 324
TABLE 411 REST OF ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 325
TABLE 412 REST OF ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 325
TABLE 413 REST OF ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 325
TABLE 414 REST OF ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 326
TABLE 415 REST OF ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 326
TABLE 416 REST OF ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 326
TABLE 417 REST OF ASIA PACIFIC: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 327
TABLE 418 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 327
TABLE 419 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 327
TABLE 420 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 328
TABLE 421 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 328
TABLE 422 LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 329
TABLE 423 LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 329
TABLE 424 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 329
TABLE 425 LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 330
TABLE 426 LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 330
TABLE 427 LATIN AMERICA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 330
TABLE 428 LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 331
TABLE 429 LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 331
TABLE 430 LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 331
TABLE 431 LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 332
TABLE 432 LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 332
TABLE 433 LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 332
TABLE 434 LATIN AMERICA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 333
TABLE 435 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 333
TABLE 436 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 333
TABLE 437 BRAZIL: KEY MACROINDICATORS 335
TABLE 438 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 335
TABLE 439 BRAZIL: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 336
TABLE 440 BRAZIL: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 336
TABLE 441 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 336
TABLE 442 BRAZIL: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 337
TABLE 443 BRAZIL: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 337
TABLE 444 BRAZIL: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 337
TABLE 445 BRAZIL: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 338
TABLE 446 BRAZIL: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 338
TABLE 447 BRAZIL: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 338
TABLE 448 BRAZIL: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 339
TABLE 449 BRAZIL: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 339
TABLE 450 BRAZIL: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 339
TABLE 451 BRAZIL: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 340
TABLE 452 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION,
2023–2030 (USD MILLION) 340
TABLE 453 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 340
TABLE 454 MEXICO: KEY MACROINDICATORS 341
TABLE 455 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 341
TABLE 456 MEXICO: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 342
TABLE 457 MEXICO: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 342
TABLE 458 MEXICO: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 342
TABLE 459 MEXICO: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 343
TABLE 460 MEXICO: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 343
TABLE 461 MEXICO: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 343
TABLE 462 MEXICO: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 344
TABLE 463 MEXICO: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 344
TABLE 464 MEXICO: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 344
TABLE 465 MEXICO: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 345
TABLE 466 MEXICO: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 345
TABLE 467 MEXICO: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 345
TABLE 468 MEXICO: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 346
TABLE 469 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION,
2023–2030 (USD MILLION) 346
TABLE 470 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 346
TABLE 471 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 347
TABLE 472 REST OF LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 348
TABLE 473 REST OF LATIN AMERICA: PAP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 348
TABLE 474 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 348
TABLE 475 REST OF LATIN AMERICA: VENTILATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 349
TABLE 476 REST OF LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 349
TABLE 477 REST OF LATIN AMERICA: INHALERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 349
TABLE 478 REST OF LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 350
TABLE 479 REST OF LATIN AMERICA: NEBULIZERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 350
TABLE 480 REST OF LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 350
TABLE 481 REST OF LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 351
TABLE 482 REST OF LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 351
TABLE 483 REST OF LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 352
TABLE 484 REST OF LATIN AMERICA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 352
TABLE 485 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 353
TABLE 486 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 353
TABLE 487 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 354
TABLE 488 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 354
TABLE 489 MIDDLE EAST & AFRICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 355
TABLE 490 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 355
TABLE 491 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 355
TABLE 492 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 356
TABLE 493 MIDDLE EAST & AFRICA: ICU VENTILATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 356
TABLE 494 MIDDLE EAST & AFRICA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 356
TABLE 495 MIDDLE EAST & AFRICA: HUMIDIFIERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 357
TABLE 496 MIDDLE EAST & AFRICA: NEBULIZERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 357
TABLE 497 MIDDLE EAST & AFRICA: RESPIRATORY CARE MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 357
TABLE 498 MIDDLE EAST & AFRICA: PULSE OXIMETERS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 358
TABLE 499 MIDDLE EAST & AFRICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 358
TABLE 500 MIDDLE EAST & AFRICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 359
TABLE 501 MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 359
TABLE 502 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 360
TABLE 503 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 360
TABLE 504 GCC COUNTRIES: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 362
TABLE 505 GCC COUNTRIES: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 362
TABLE 506 GCC COUNTRIES: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 363
TABLE 507 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 363
TABLE 508 GCC COUNTRIES: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 363
TABLE 509 GCC COUNTRIES: ICU VENTILATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 364
TABLE 510 GCC COUNTRIES: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 364
TABLE 511 GCC COUNTRIES: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 364
TABLE 512 GCC COUNTRIES: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 365
TABLE 513 GCC COUNTRIES: RESPIRATORY CARE MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 365
TABLE 514 GCC COUNTRIES: PULSE OXIMETERS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 365
TABLE 515 GCC COUNTRIES: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 366
TABLE 516 GCC COUNTRIES: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 366
TABLE 517 GCC COUNTRIES: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 366
TABLE 518 GCC COUNTRIES: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 367
TABLE 519 GCC COUNTRIES: RESPIRATORY CARE DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 367
TABLE 520 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 368
TABLE 521 REST OF MIDDLE EAST & AFRICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 368
TABLE 522 REST OF MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 369
TABLE 523 REST OF MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 369
TABLE 524 REST OF MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 369
TABLE 525 REST OF MIDDLE EAST & AFRICA: ICU VENTILATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 370
TABLE 526 REST OF MIDDLE EAST & AFRICA: INHALERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 370
TABLE 527 REST OF MIDDLE EAST & AFRICA: HUMIDIFIERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 370
TABLE 528 REST OF MIDDLE EAST & AFRICA: NEBULIZERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 371
TABLE 529 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 371
TABLE 530 REST OF MIDDLE EAST & AFRICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 371
TABLE 531 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 372
TABLE 532 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 372
TABLE 533 REST OF MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE,
2023–2030 (USD MILLION) 372
TABLE 534 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET,
BY DISEASE INDICATION, 2023–2030 (USD MILLION) 373
TABLE 535 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 373
TABLE 536 STRATEGIES ADOPTED BY KEY PLAYERS IN RESPIRATORY CARE DEVICES MARKET, JANUARY 2021–APRIL 2025 375
TABLE 537 RESPIRATORY CARE DEVICES MARKET: DEGREE OF COMPETITION 379
TABLE 538 RESPIRATORY CARE DEVICES MARKET: REGION FOOTPRINT 384
TABLE 539 RESPIRATORY CARE DEVICES MARKET: PRODUCT TYPE FOOTPRINT 385
TABLE 540 RESPIRATORY CARE DEVICES MARKET: DISEASE INDICATION FOOTPRINT 386
TABLE 541 RESPIRATORY CARE DEVICES MARKET: END USER FOOTPRINT 387
TABLE 542 RESPIRATORY CARE DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 390
TABLE 543 RESPIRATORY CARE DEVICES MARKET: COMPETITIVE BENCHMARKING
OF KEY STARTUPS/SMES 390
TABLE 544 RESPIRATORY CARE DEVICES MARKET: PRODUCT & SERVICE
LAUNCHES AND APPROVALS, JANUARY 2021–APRIL 2025 393
TABLE 545 RESPIRATORY CARE DEVICES MARKET: DEALS, JANUARY 2021–APRIL 2025 394
TABLE 546 RESPIRATORY CARE DEVICES MARKET: EXPANSIONS, JANUARY 2021–APRIL 2025 395
TABLE 547 RESPIRATORY CARE DEVICES MARKET: OTHER DEVELOPMENTS,
JANUARY 2021– APRIL 2025 395
TABLE 548 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 396
TABLE 549 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–APRIL 2025 399
TABLE 550 MEDTRONIC: COMPANY OVERVIEW 401
TABLE 551 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–APRIL 2025 403
TABLE 552 MEDTRONIC PLC: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2025 404
TABLE 553 RESMED INC.: COMPANY OVERVIEW 405
TABLE 554 RESMED INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025 408
TABLE 555 RESMED INC: DEALS, JANUARY 2021–APRIL 2025 409
TABLE 556 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW 411
TABLE 557 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025 414
TABLE 558 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW 417
TABLE 559 DRÄGERWERK AG & CO. KGAA: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–APRIL 2025 419
TABLE 560 DRÄGERWERK AG & CO. KGAA: DEALS, JANUARY 2021–APRIL 2025 420
TABLE 561 DRÄGERWERK AG & CO. KGAA: OTHER DEVELOPMENTS,
JANUARY 2021–APRIL 2025 420
TABLE 562 MASIMO: COMPANY OVERVIEW 422
TABLE 563 MASIMO: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025 425
TABLE 564 MASIMO: DEALS, JANUARY 2021–APRIL 2025 426
TABLE 565 MASIMO: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2025 426
TABLE 566 GETINGE: COMPANY OVERVIEW 427
TABLE 567 GETINGE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025 429
TABLE 568 GETINGE: DEALS, JANUARY 2021–APRIL 2025 429
TABLE 569 GETINGE: EXPANSIONS, JANUARY 2021–APRIL 2025 430
TABLE 570 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 431
TABLE 571 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–APRIL 2025 433
TABLE 572 NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021–APRIL 2025 434
TABLE 573 GE HEALTHCARE: COMPANY OVERVIEW 435
TABLE 574 GE HEALTHCARE: DEALS, JANUARY 2021–APRIL 2025 437
TABLE 575 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025 437
TABLE 576 HILLROM & WELCH ALLYN (BAXTER): COMPANY OVERVIEW 438
TABLE 577 HILLROM & WELCH ALLYN (BAXTER): PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MARCH 2024 440
TABLE 578 HILLROM & WELCH ALLYN (BAXTER): DEALS, JANUARY 2021–MARCH 2024 441
TABLE 579 ADAPTHEALTH, LLC: COMPANY OVERVIEW 442
TABLE 580 TELEFLEX INCORPORATED: COMPANY OVERVIEW 444
TABLE 581 AIR LIQUIDE: COMPANY OVERVIEW 446
TABLE 582 AIR LIQUIDE: DEALS, JANUARY 2021–APRIL 2025 449
TABLE 583 ICU MEDICAL, INC.: COMPANY OVERVIEW 450
TABLE 584 ICU MEDICAL, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–APRIL 2025 452
TABLE 585 ICU MEDICAL, INC.: DEALS, JANUARY 2021–MARCH 2024 452
TABLE 586 HAMILTON MEDICAL: COMPANY OVERVIEW 453
TABLE 587 HAMILTON MEDICAL: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–MARCH 2024 454
LIST OF FIGURES
FIGURE 1 RESPIRATORY CARE DEVICES MARKET SEGMENTATION 39
FIGURE 2 RESEARCH DESIGN 43
FIGURE 3 PRIMARY SOURCES 46
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 48
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE),
BY COMPANY TYPE, DESIGNATION, AND REGION 48
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE), BY END USER, DESIGNATION, AND REGION 49
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 50
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: RESMED INC. 50
FIGURE 9 SUPPLY-SIDE MARKET ESTIMATION: RESPIRATORY CARE DEVICES MARKET (2024) 51
FIGURE 10 DEMAND-SIDE MARKET ESTIMATION: RESPIRATORY
CARE DEVICES MARKET (2024) 52
FIGURE 11 TOTAL MARKET SIZE ESTIMATION: RESPIRATORY CARE DEVICES MARKET 52
FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030) 54
FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 55
FIGURE 14 TOP-DOWN APPROACH 56
FIGURE 15 MARKET DATA TRIANGULATION METHODOLOGY 57
FIGURE 16 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT,
2025 VS. 2030 (USD MILLION) 59
FIGURE 17 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION,
2025 VS. 2030 (USD MILLION) 60
FIGURE 18 RESPIRATORY CARE DEVICES MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 60
FIGURE 19 GEOGRAPHIC SNAPSHOT: RESPIRATORY CARE DEVICES MARKET 61
FIGURE 20 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET GROWTH DURING FORECAST PERIOD 63
FIGURE 21 INDIA ACCOUNTED FOR LARGEST SHARE OF RESPIRATORY CARE DEVICES MARKET IN ASIA PACIFIC IN 2024 64
FIGURE 22 INDIA TO GROW AT HIGHEST RATE DURING FORECAST PERIOD 65
FIGURE 23 NORTH AMERICA WILL CONTINUE TO DOMINATE RESPIRATORY CARE DEVICES MARKET DURING FORECAST PERIOD 65
FIGURE 24 DEVELOPING MARKETS TO REGISTER FASTEST GROWTH
DURING FORECAST PERIOD 66
FIGURE 25 RESPIRATORY CARE DEVICES MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 67
FIGURE 26 GLOBAL GERIATRIC POPULATION, BY REGION 69
FIGURE 27 ANNUAL DATA OF DEATHS CAUSED BY HOUSEHOLD AND AMBIENT
AIR POLLUTION, BY DISEASE 70
FIGURE 28 IMPACT OF INNOVATIVE SOLUTIONS 89
FIGURE 29 INTRODUCTION OF INNOVATIVE SOLUTIONS FOR SLEEP APNEA TREATMENT 90
FIGURE 30 VALUE CHAIN ANALYSIS 91
FIGURE 31 SUPPLY CHAIN ANALYSIS 92
FIGURE 32 ADJACENT MARKETS FOR RESPIRATORY CARE DEVICES MARKET 97
FIGURE 33 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR RESPIRATORY CARE DEVICES MARKET 98
FIGURE 34 TOP PATENT APPLICANT COUNTRIES FOR RESPIRATORY CARE DEVICES
(JANUARY 2014–DECEMBER 2024) 99
FIGURE 35 RESPIRATORY CARE DEVICES MARKET: ECOSYSTEM MARKET MAP 100
FIGURE 36 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN RESPIRATORY CARE DEVICES MARKET 104
FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR
RESPIRATORY CARE DEVICES 104
FIGURE 38 KEY BUYING CRITERIA FOR RESPIRATORY CARE DEVICES 105
FIGURE 39 RESPIRATORY CARE DEVICES MARKET: REGIONAL GROWTH OPPORTUNITIES 214
FIGURE 40 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET SNAPSHOT 216
FIGURE 41 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET SNAPSHOT 283
FIGURE 42 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN RESPIRATORY CARE DEVICES MARKET (2020−2024) 377
FIGURE 43 RESPIRATORY CARE DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER (2024) 378
FIGURE 44 RESPIRATORY CARE DEVICES MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 382
FIGURE 45 RESPIRATORY CARE DEVICES MARKET: COMPANY FOOTPRINT 383
FIGURE 46 RESPIRATORY CARE DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 389
FIGURE 47 EV/EBITDA OF KEY VENDORS 391
FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 391
FIGURE 49 RESPIRATORY CARE DEVICES MARKET: BRAND/PRODUCT
COMPARATIVE ANALYSIS 392
FIGURE 50 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024) 397
FIGURE 51 MEDTRONIC: COMPANY SNAPSHOT (2024) 402
FIGURE 52 RESMED INC.: COMPANY SNAPSHOT (2024) 406
FIGURE 53 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2024) 412
FIGURE 54 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2024) 418
FIGURE 55 MASIMO: COMPANY SNAPSHOT (2024) 423
FIGURE 56 GETINGE: COMPANY SNAPSHOT (2024) 428
FIGURE 57 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023) 432
FIGURE 58 GE HEALTHCARE: COMPANY SNAPSHOT (2024) 436
FIGURE 59 HILLROM & WELCH ALLYN (BAXTER): COMPANY SNAPSHOT (2024) 439
FIGURE 60 ADAPTHEALTH, LLC: COMPANY SNAPSHOT (2024) 442
FIGURE 61 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2024) 445
FIGURE 62 AIR LIQUIDE: COMPANY SNAPSHOT (2024) 447
FIGURE 63 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024) 451
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11